There were 1,499 press releases posted in the last 24 hours and 429,344 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
NewLink Genetics Corporation to Present Phase 1b Data on Indoximod in Combination Therapy in Patients With Metastatic Pancreatic Cancer at ASCO GI

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image